In this connection, both nonselective and COX-2-selective NSAIDs were found to reduce glomerular filtration, increase fluid retention and blood pressure [5, 6], and some highly selective COX-2 inhibitors were found unfavourable in patients with cardiovascular diseases and were withdrawn from the market [5, 35]. Here, PTGS2 is linked to cardiovascular disorder.